Previous studies that enrolled healthy persons and individuals with obesity and type 2 diabetes had reported similar findings of an inverse association between plasma levels of long-chain dihydroceramides (including C18:0, C20:0, and C22:0) and insulin sensitivity [9, 18]. The gene discussed is INS; the disease is obesity disorder.